Covered recipient · General Payments record
VENUGOPAL R DAMERLA
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2020–2024
$1,615.28
- Reported across 28 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $927.96 | 12 |
| Education | $454.02 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Legend Biotech USA Inc. | $327.39 | 8 |
| Acerta Pharma LLC | $249.98 | 2 |
| SEAGEN INC. | $174.98 | 2 |
| Blueprint Medicines Corporation | $124.99 | 1 |
| AVEO Pharmaceuticals, Inc. | $123.67 | 1 |
| Janssen Biotech, Inc. | $115.68 | 1 |
| Incyte Corporation | $99.00 | 1 |
| Lilly USA, LLC | $53.12 | 2 |
| EISAI INC. | $33.18 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $29.09 | 1 |
| JAZZ PHARMACEUTICALS INC. | $25.69 | 1 |
| ABBVIE INC. | $25.21 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (22)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $25.21 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103531225 | CMS |
| AstraZeneca Pharmaceuticals LP | $124.99 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104731985 | CMS |
| AstraZeneca Pharmaceuticals LP | $124.99 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105619845 | CMS |
| Aveo Pharmaceuticals, Inc. | $123.67 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143488038 | CMS |
| Blueprint Medicines Corporation | $124.99 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147449224 | CMS |
| Eisai Inc. | $33.18 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110787079 | CMS |
| Incyte Corporation | $99.00 | 04/01/2024 | Education | Undisputed | 01/23/2026 | 1141308927 | CMS |
| Janssen Biotech, Inc. | $115.68 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078367156 | CMS |
| JAZZ PHARMACEUTICALS INC. | $25.69 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150222770 | CMS |
| Legend Biotech USA Inc. | $147.35 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131689957 | CMS |
| Legend Biotech USA Inc. | $25.72 | 11/07/2024 | Education | Undisputed | 01/23/2026 | 1131694954 | CMS |
| Legend Biotech USA Inc. | $25.72 | 11/07/2024 | Education | Undisputed | 01/23/2026 | 1131694962 | CMS |
| Legend Biotech USA Inc. | $25.72 | 11/07/2024 | Education | Undisputed | 01/23/2026 | 1131694967 | CMS |
| Legend Biotech USA Inc. | $25.72 | 11/07/2024 | Education | Undisputed | 01/23/2026 | 1131694977 | CMS |
| Legend Biotech USA Inc. | $25.72 | 11/07/2024 | Education | Undisputed | 01/23/2026 | 1131694984 | CMS |
| Legend Biotech USA Inc. | $25.72 | 11/07/2024 | Education | Undisputed | 01/23/2026 | 1131695001 | CMS |
| Legend Biotech USA Inc. | $25.72 | 11/07/2024 | Education | Undisputed | 01/23/2026 | 1131695009 | CMS |
| Lilly USA, LLC | $25.09 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135474622 | CMS |
| Lilly USA, LLC | $28.03 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135506340 | CMS |
| SEAGEN INC. | $99.99 | 09/18/2024 | Education | Undisputed | 01/23/2026 | 1131907141 | CMS |
| SEAGEN INC. | $74.99 | 09/18/2024 | Education | Undisputed | 01/23/2026 | 1131907145 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $29.09 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144955875 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2020, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2020 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.